Group One Trading
CBAY

Group One Trading’s Cymabay Therapeutics CBAY Stock Holding History

Group One Trading’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-470,500
Closed -$11.1M – 8202
2023
Q4 		$11.1M Buy
470,500
+391,900
+499% +$6.98M 0.03% 640
2023
Q3 		$1.17M Sell
78,600
-1,600
-2% -$21.2K ﹤0.01% 2102
2023
Q2 		$878K Sell
80,200
-5,500
-6% -$51.2K ﹤0.01% 2475
2023
Q1 		$747K Buy
85,700
+57,700
+206% +$462K ﹤0.01% 2384
2022
Q4 		$176K Buy
28,000
+24,500
+700% +$93.1K ﹤0.01% 3963
2022
Q3 		$12K Sell
3,500
-26,000
-88% -$93.4K ﹤0.01% 6401
2022
Q2 		$87K Buy
29,500
+12,000
+69% +$28.7K ﹤0.01% 5118
2022
Q1 		$54K Sell
17,500
-25,900
-60% -$81.5K ﹤0.01% 6046
2021
Q4 		$147K Sell
43,400
-10,300
-19% -$39.1K ﹤0.01% 5393
2021
Q3 		$196K Buy
53,700
+11,800
+28% +$46.5K ﹤0.01% 5195
2021
Q2 		$183K Buy
41,900
+19,200
+85% +$85.1K ﹤0.01% 5332
2021
Q1 		$103K Sell
22,700
-12,100
-35% -$65.1K ﹤0.01% 5639
2020
Q4 		$200K Sell
34,800
-29,200
-46% -$221K ﹤0.01% 4060
2020
Q3 		$463K Sell
64,000
-122,600
-66% -$656K ﹤0.01% 2913
2020
Q2 		$651K Buy
186,600
+120,000
+180% +$346K ﹤0.01% 2414
2020
Q1 		$99K Buy
66,600
+53,800
+420% +$90.3K ﹤0.01% 3304
2019
Q4 		$25K Sell
12,800
-123,200
-91% -$463K ﹤0.01% 4291
2019
Q3 		$696K Sell
136,000
-53,000
-28% -$321K 0.01% 2057
2019
Q2 		$1.35M Buy
189,000
+137,900
+270% +$1.56M 0.01% 1374
2019
Q1 		$679K Buy
51,100
+48,600
+1,944% +$517K 0.01% 1704
2018
Q4 		$20K Sell
2,500
-2,000
-44% -$19K ﹤0.01% 4026
2018
Q3 		$50K Buy
4,500
+600
+15% +$7.45K ﹤0.01% 3973
2018
Q2 		$52K Buy
+3,900
New +$48.8K ﹤0.01% 3932
2018
Q1 		– Sell
-26,800
Closed -$247K – 5415
2017
Q4 		$247K Buy
26,800
+4,800
+22% +$41K ﹤0.01% 2793
2017
Q3 		$177K Buy
22,000
+16,600
+307% +$112K ﹤0.01% 2846
2017
Q2 		$31K Buy
+5,400
New +$23K ﹤0.01% 3762

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Group One Trading's CBAY Position: Q4 2023 in Review

Group One Trading sold out of Cymabay Therapeutics (CBAY) in Q4 2023, closing a stake of 23,495 shares — an estimated $418K sold.

Group One Trading first reported a position in CBAY in Q2 2017 and held it in 11 quarters. The position peaked at $350K in Q3 2023. 200 funds tracked by Wall St. Rank hold CBAY as of Q4 2023.

  • Group One Trading reported no remaining Cymabay Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 23,495 Cymabay Therapeutics shares in Q4 2023, an estimated $418K.
  • Group One Trading first reported a position in Cymabay Therapeutics in Q2 2017 and held it in 11 quarters.
  • Group One Trading's Cymabay Therapeutics position peaked at $350K in Q3 2023.
  • 200 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.